Caitriona M. O'Driscoll
Affiliations: | School of Pharmacy | University College Cork, Cork, County Cork, Ireland |
Google:
"Caitriona O'Driscoll"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mendonça MCP, Sun Y, Cronin MF, et al. (2023) Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin. Pharmaceutics. 15 |
| Knox EG, Aburto MR, Tessier C, et al. (2022) Microbial-derived metabolites induce actin cytoskeletal rearrangement and protect blood-brain barrier function. Iscience. 25: 105648 |
| Knox EG, Lynch CMK, Lee YS, et al. (2022) The gut microbiota is important for the maintenance of blood-cerebrospinal fluid barrier integrity. The European Journal of Neuroscience |
| Kont A, Mendonça MCP, Cronin MF, et al. (2022) Co-Formulation of Amphiphilic Cationic and Anionic Cyclodextrins Forming Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukaemia. International Journal of Molecular Sciences. 23 |
| Knox EG, Aburto MR, Clarke G, et al. (2022) The blood-brain barrier in aging and neurodegeneration. Molecular Psychiatry |
| Sun D, Zou Y, Song L, et al. (2021) A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharmaceutica Sinica. B. 12: 378-393 |
| Mendonça MCP, Cronin MF, Cryan JF, et al. (2021) Modified cyclodextrin-based nanoparticles mediated delivery of siRNA for huntingtin gene silencing across an in vitro BBB model. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 169: 309-318 |
| Zou Y, Xiao F, Song L, et al. (2021) A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer. International Journal of Pharmaceutics. 120888 |
| Mendonça MCP, Kont A, Aburto MR, et al. (2021) Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System. Molecular Pharmaceutics |
| Presas E, Tovar S, Cuñarro J, et al. (2020) Pre-clinical evaluation of a modified cyclodextrin-based nanoparticle for intestinal delivery of Liraglutide. Journal of Pharmaceutical Sciences |